![Ryszard Kole](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ryszard Kole
Geen lopende functies
Loopbaan van Ryszard Kole
Eerdere bekende functies van Ryszard Kole
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Ercole Biotech, Inc.
![]() Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Hoofd Techniek/Wetenschap/O&O | 01-01-2001 | - |
President | 01-01-2001 | - | |
The University of North Carolina at Charlotte | Corporate Officer/Principal | - | - |
SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 10-04-2008 | - |
Opleiding van Ryszard Kole
Polish Academy of Sciences | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Polen | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
President | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SAREPTA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Ercole Biotech, Inc.
![]() Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Commercial Services |
- Beurs
- Insiders
- Ryszard Kole
- Ervaring